Tarsus Pharmaceuticals Inc (TARS)
38.96
+0.38
(+0.98%)
USD |
NASDAQ |
May 20, 14:32
Tarsus Pharmaceuticals 1 Year Total Returns (Daily): 140.1% for May 17, 2024
1 Year Total Returns (Daily) Chart
Historical 1 Year Total Returns (Daily) Data
| Date | Value |
|---|---|
| May 17, 2024 | 140.1% |
| May 16, 2024 | 137.4% |
| May 15, 2024 | 132.5% |
| May 14, 2024 | 130.4% |
| May 13, 2024 | 132.7% |
| May 10, 2024 | 121.6% |
| May 09, 2024 | 111.6% |
| May 08, 2024 | 139.6% |
| May 07, 2024 | 147.8% |
| May 06, 2024 | 141.2% |
| May 03, 2024 | 143.9% |
| May 02, 2024 | 138.5% |
| May 01, 2024 | 113.5% |
| April 30, 2024 | 110.7% |
| April 29, 2024 | 115.3% |
| April 26, 2024 | 121.9% |
| April 25, 2024 | 124.6% |
| April 24, 2024 | 124.1% |
| April 23, 2024 | 125.5% |
| April 22, 2024 | 116.0% |
| April 19, 2024 | 134.2% |
| April 18, 2024 | 148.5% |
| April 17, 2024 | 174.0% |
| April 16, 2024 | 201.6% |
| April 15, 2024 | 202.0% |
| Date | Value |
|---|---|
| April 12, 2024 | 201.4% |
| April 11, 2024 | 214.1% |
| April 10, 2024 | 191.7% |
| April 09, 2024 | 188.5% |
| April 08, 2024 | 180.1% |
| April 05, 2024 | 184.1% |
| April 04, 2024 | 180.0% |
| April 03, 2024 | 185.4% |
| April 02, 2024 | 183.1% |
| April 01, 2024 | 185.2% |
| March 28, 2024 | 197.0% |
| March 27, 2024 | 184.1% |
| March 26, 2024 | 183.9% |
| March 25, 2024 | 185.9% |
| March 22, 2024 | 179.2% |
| March 21, 2024 | 160.9% |
| March 20, 2024 | 158.4% |
| March 19, 2024 | 147.2% |
| March 18, 2024 | 140.1% |
| March 15, 2024 | 129.8% |
| March 14, 2024 | 105.7% |
| March 13, 2024 | 120.9% |
| March 12, 2024 | 114.7% |
| March 11, 2024 | 113.9% |
| March 08, 2024 | 122.2% |
Total Return Definition
The Total return is the change in price over a specific period of time that includes dividends and distributions paid.
1 Year Total Returns (Daily) Range, Past 5 Years
-65.87%
Minimum
Jun 10 2022
214.1%
Maximum
Apr 11 2024
1.63%
Average
-20.02%
Median
1 Year Total Returns (Daily) Benchmarks
| Pacira BioSciences Inc | -23.81% |
| Unicycive Therapeutics Inc | -25.71% |
| CEL-SCI Corp | -52.96% |
| AIM ImmunoTech Inc | -19.40% |
| IGC Pharma Inc | 69.70% |